Pancreatic cancer remains one of the deadliest forms of cancer, but new research is offering fresh hope. A recently FDA-approved drug is showing promise in improving treatment outcomes, raising optimism among doctors and patients. At the same time, scientists are studying bats, whose unique biology may hold valuable clues about cancer resistance and longevity.


Pancreatic cancer breakthrough? New FDA-approved drug sparks hope

fdahealth

Fdahealth, News on Fdahealth, stories on Fdahealth, articles on Fdahealth, Fdahealth stories at Wion, Fdahealth news, Fdahealth latest news